0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Acute Leukemia After Radioactive Iodine (I131) Therapy for Hyperthyroidism

THOMAS W. BURNS, M.D.; RAYMOND VICKERS, M.D.; JOHN F. LOWNEY, M.D.
Arch Intern Med. 1960;106(1):97-100. doi:10.1001/archinte.1960.03820010099014.
Text Size: A A A
Published online

During the 13 years since radioactive iodine, I131, became available, there has been little direct evidence to cast doubt on its safety. Attention has been focused largely on the possibility that radioactive iodine therapy for hyperthyroidism would lead to a higher incidence of cancer of the thyroid.1,2 This concern is based on the obvious fact that thyroid tissue is by far the most heavily irradiated after radioactive iodine administration, by the observation that there is an increased incidence of carcinoma of the thyroid in children treated with x-ray therapy of the thymus,3,4 and by animal experiments in which carcinoma of the thyroid was produced by irradiation.5 Recently, the occurrence of adenomata in three patients who had received radioactive iodine therapy for hyperthyroidism before the age of 20 has been reported.6 In one of these, the pathological findings were interpreted as "low-grade follicular carcinoma."

The possibility that radioactive iodine may be

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();